Ibrutinib in Relapsed or Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma: Final Results from a Prospective Phase II Study

被引：1
|
作者：
Graf, Solomon A. [1 ]
Cassaday, Ryan D. [1 ]
Morris, Karolyn K. [1 ]
Behnia, Sanaz [2 ]
Wu, Qian Vicky [3 ]
Voutsinas, Jenna M. [3 ]
Lynch, Ryan C. [1 ]
Krakow, Elizabeth [1 ]
Rasmussen, Heather A. [1 ]
Chauncey, Thomas R. [1 ]
Kanan, Sandra [1 ]
Soma, Lorinda A. [4 ]
Smith, Stephen D. [1 ]
Gopal, Ajay K. [1 ]
机构：
[1] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA
[2] Univ Washington, Dept Radiol, Seattle, WA 98195 USA
[3] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[4] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-126086
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1596
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Ibrutinib Is Effective in Relapsed or Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma: Results from a Prospective Phase II Study
    Graf, Solomon A.
    Cassaday, Ryan D.
    Morris, Karolyn K.
    Rasmussen, Heather A.
    Becker, Pamela S.
    Chauncey, Thomas R.
    Kanan, Sandra
    Soma, Lorinda A.
    Smith, Stephen D.
    Gopal, Ajay K.
    [J]. BLOOD, 2018, 132
  • [2] Radioimmunotherapy for Indolent B-Cell Non-Hodgkin Lymphoma in Relapsed, Refractory and Transformed Disease
    Otto J. Visser
    Lars R. Perk
    Josée M. Zijlstra
    Guus A.M.S. van Dongen
    Peter C. Huijgens
    Arjan A. van de Loosdrecht
    [J]. BioDrugs, 2006, 20 : 201 - 207
  • [3] Radioimmunotherapy for indolent B-cell non-Hodgkin lymphoma in relapsed, refractory and transformed disease
    Visser, Otto J.
    Perk, Lars R.
    Zijlstra, Josee M.
    van Dongen, Guus A. M. S.
    Huijgens, Peter C.
    van de Loosdrecht, Arjan A.
    [J]. BIODRUGS, 2006, 20 (04) : 201 - 207
  • [4] Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
    Ohmachi, Ken
    Ando, Kiyoshi
    Ogura, Michinori
    Uchida, Toshiki
    Itoh, Kuniaki
    Kubota, Nobuko
    Ishizawa, Kenichi
    Yamamoto, Joji
    Watanabe, Takashi
    Uike, Naokuni
    Choi, Ilseung
    Terui, Yasuhito
    Usuki, Kensuke
    Nagai, Hirokazu
    Uoshima, Nobuhiko
    Tobinai, Kensei
    [J]. CANCER SCIENCE, 2010, 101 (09) : 2059 - 2064
  • [5] Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma
    Hamadani, Mehdi
    Radford, John
    Carlo-Stella, Carmelo
    Caimi, Paolo F.
    Reid, Erin
    O'Connor, Owen A.
    Feingold, Jay M.
    Ardeshna, Kirit M.
    Townsend, William
    Solh, Melhem
    Heffner, Leonard T.
    Ungar, David
    Wang, Luqiang
    Boni, Joseph
    Havenith, Karin
    Qin, Yajuan
    Kahl, Brad S.
    [J]. BLOOD, 2021, 137 (19) : 2634 - 2645
  • [6] A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
    Ogura, Michinori
    Ando, Kiyoshi
    Suzuki, Tatsuya
    Ishizawa, Kenichi
    Oh, Sung Yong
    Itoh, Kuniaki
    Yamamoto, Kazuhito
    Au, Wing Yan
    Tien, Hwei-Fang
    Matsuno, Yoshihiro
    Terauchi, Takashi
    Yamamoto, Keiko
    Mori, Masahiko
    Tanaka, Yoshinobu
    Shimamoto, Takashi
    Tobinai, Kensei
    Kim, Won Seog
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (06) : 768 - 776
  • [7] Updated Results of a Phase I Study of Ibrutinib and Lenalidomide in Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma
    Christian, Beth A.
    Kuruvilla, John G.
    Smith, Sonali M.
    Porcu, Pierluigi
    Maddocks, Kami J.
    Ruppert, Amy S.
    Byrd, John C.
    Grever, Michael R.
    Blum, Kristie A.
    [J]. BLOOD, 2015, 126 (23)
  • [8] A Phase I Study of Ibrutinib and Lenalidomide in Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma
    Christian, Beth
    Kuruvilla, John
    Smith, Sonali
    Porcu, Pierluigi
    Ruppert, Amy S.
    Byrd, John C.
    Grever, Michael R.
    Blum, Kristie A.
    [J]. BLOOD, 2014, 124 (21)
  • [9] Phase II study of oral fludarabine phosphate in relapsed indolent B-cell non-Hodgkin's lymphoma
    Tobinai, K
    Watanabe, T
    Ogura, M
    Morishima, Y
    Ogawa, Y
    Ishizawa, KI
    Minami, H
    Utsunomiya, A
    Taniwaki, M
    Terauchi, T
    Nawano, S
    Matsusako, M
    Matsuno, Y
    Nakamura, S
    Mori, S
    Ohashi, Y
    Hayashi, M
    Seriu, T
    Hotta, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (01) : 174 - 180
  • [10] Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
    Tobinai, Kensei
    Ishizawa, Ken-ichi
    Ogura, Michinori
    Itoh, Kuniaki
    Morishima, Yasuo
    Ando, Kiyoshi
    Taniwaki, Masafumi
    Watanabe, Takashi
    Yamamoto, Joji
    Uchida, Toshiki
    Nakata, Masanobu
    Terauchi, Takashi
    Nawano, Shigeru
    Matsusako, Masaki
    Hayashi, Masaki
    Hotta, Tomomitsu
    [J]. CANCER SCIENCE, 2009, 100 (10) : 1951 - 1956
12345